Education
About Us
Working with TipRanks
Follow Us
MediPharm Labs (TSE:LABS)
TSX:LABS
LABS Stock Chart & Stats
Day’s Range― - ―
52-Week RangeC$0.06 - C$0.12
Previous CloseN/A
Volume690.59K
Average Volume (3M)144.84K
Market Cap
$31.56M
Enterprise ValueC$13.60M
Total Cash (Recent Filing)$8.44M
Total Debt (Recent Filing)$125.00K
Price to Earnings (P/E)―
Beta0.62
Next Earnings
Nov 17, 2025EPS Estimate
>-0.01Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.01
Shares Outstanding420,755,000
10 Day Avg. Volume236,172
30 Day Avg. Volume144,845
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market Cap0.43
Enterprise Value/Revenue0.32
Enterprise Value/Gross Profit0.95
Enterprise Value/Ebitda-2.86
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusHold
Number of Analyst Covering1
MediPharm Labs News
LABS FAQ
What was MediPharm Labs’s price range in the past 12 months?
MediPharm Labs lowest stock price was C$0.06 and its highest was C$0.12 in the past 12 months.
What is MediPharm Labs’s market cap?
MediPharm Labs’s market cap is $31.56M.
When is MediPharm Labs’s upcoming earnings report date?
MediPharm Labs’s upcoming earnings report date is Nov 17, 2025 which is in 94 days.
How were MediPharm Labs’s earnings last quarter?
MediPharm Labs released its earnings results on Aug 14, 2025. The company reported -C$0.01 earnings per share for the quarter, missing the consensus estimate of -C$0.002 by -C$0.008.
Is MediPharm Labs overvalued?
According to Wall Street analysts MediPharm Labs’s price is currently Overvalued.
Does MediPharm Labs pay dividends?
MediPharm Labs does not currently pay dividends.
What is MediPharm Labs’s EPS estimate?
MediPharm Labs’s EPS estimate is >-0.01.
How many shares outstanding does MediPharm Labs have?
MediPharm Labs has 420,755,000 shares outstanding.
What happened to MediPharm Labs’s price movement after its last earnings report?
MediPharm Labs reported an EPS of -C$0.01 in its last earnings report, missing expectations of -C$0.002. Following the earnings report the stock price went up 5.263%.
Which hedge fund is a major shareholder of MediPharm Labs?
Currently, no hedge funds are holding shares in TSE:LABS
Company Description
MediPharm Labs
MediPharm Labs (LABS) is a leading Canadian pharmaceutical company specializing in the production and distribution of high-quality cannabis oil and derivatives. The company operates within the cannabis sector, focusing on advanced manufacturing processes to create a range of products, including medical cannabis oils, concentrates, and other cannabinoid formulations. MediPharm Labs is committed to innovation and quality, serving both the medical and recreational markets while adhering to stringent regulatory standards.
LABS Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call highlighted significant improvements in financial performance with record gross profit margins, positive adjusted EBITDA, and strong international revenue growth. However, challenges remain in the Canadian market, and there is an ongoing dispute with an activist shareholder. The overall sentiment is optimistic about continued growth and stability.View all TSE:LABS earnings summariesLABS Stock 12 Month Forecast
Average Price Target
―Technical Analysis
iAnthus Capital Holdings
―
Decibel Cannabis Company
―
Vext Science
―
Ayr Wellness
―
Avicanna
―
Ownership Overview
8.78% Insiders
―
Mutual Funds
― Other Institutional Investors
91.22% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---